Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XVI.g

Alveolar hemorrhage, diffuse (ANCA-positive/-related)

(Fr: Hémorragie alvéolaire avec ANCA (divers types possibles). See also under III a (bland DAH) and XII: ANCA-related vasculitis.

Publications

Cubuk A, Weinberger S, Moldovan ED, Schaeff V, Neymeyer J

Use of the Allium Round Posterior Stent for the Treatment of Recurrent Vesicourethral Anastomosis Stricture.

Urology 2023 Jul 08;; — 2023 Jul 08

Alawneh D, Edrees A

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review.

Cureus 2022 Apr;14;e24132 — 2022 Apr — e24132

Russe-Russe JR, Pellegrini JR, Alvarez-Betancourt A, Munshi RF, Anand P

Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use.

Cureus 2021 Oct;13;e18974 — 2021 Oct — e18974

Paley MA, Edrees F, Kudose S, Gaut JP, Ranganathan P, Vijayan A

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2019 Jan-Feb;30;226-230 — 2019 Jan-Feb — 226-230

Agarwal G, Sultan G, Werner SL, Hura C

Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary renal syndrome.

Case reports in nephrology 2014;2014;868590 — 2014 — 868590

Kalra A, Yokogawa N, Raja H, Palaniswamy C, Desai P, Zanotti-Cavazzoni SL, Rajaram SS

Hydralazine-induced pulmonary-renal syndrome: a case report.

American journal of therapeutics 2012 Jul;19;e136-8 — 2012 Jul — e136-8